FundedIQ
Biotechnology

Sprout Pharmaceuticals: Funding, Investors & Team (Oct 2026)

Sprout Pharmaceuticals develops products for the treatment of female sexual dysfunction. They're committed to breakthrough firsts in women’s sexual health. The company was incorporated in 2011 and is based in Raleigh, North Carolina.

sproutpharmaceuticals.com LinkedIn Raleigh, United States 51-100 employees
Biotechnology Health Care Medical Pharmaceutical
Total raised
$25.1M
Rounds
1
Latest
Convertible Note
May 2022

Sprout Pharmaceuticals has raised $25.1M across 1 funding round on record, the most recent a Convertible Note of $25.1M announced in May 2022.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Sprout Pharmaceuticals Company Profile and Key Stats

Total funding raised
$25.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Convertible Note
$25.1M in May 2022
Employees
51-100
reported band
Headquarters
Raleigh, United States

Latest funding round on record: May 2022.

Sprout Pharmaceuticals Funding Rounds

Date
Round
Amount
Convertible Note
$25.1M

Sprout Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Robert Whitehead
CEO
—

No contact details are on record for this team yet.

Sprout Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Sprout Pharmaceuticals' latest round of $25.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Sprout Pharmaceuticals in Biotechnology and Raleigh

Companies Similar to Sprout Pharmaceuticals

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Sprout Pharmaceuticals Funding FAQs

What does Sprout Pharmaceuticals do?

Sprout Pharmaceuticals develops products for the treatment of female sexual dysfunction. They're committed to breakthrough firsts in women’s sexual health. The company was incorporated in 2011 and is based in Raleigh, North Carolina.

How much funding has Sprout Pharmaceuticals raised?

Sprout Pharmaceuticals has raised $25.1M across 1 round on record. The most recent is a Convertible Note of $25.1M announced in May 2022.

When did Sprout Pharmaceuticals last raise funding?

Sprout Pharmaceuticals' most recent funding round on record is a Convertible Note of $25.1M, announced in May 2022.

Who is the CEO of Sprout Pharmaceuticals?

Robert Whitehead is listed as CEO at Sprout Pharmaceuticals.

Where is Sprout Pharmaceuticals headquartered?

Sprout Pharmaceuticals is based in Raleigh, North Carolina, United States.

How many employees does Sprout Pharmaceuticals have?

Sprout Pharmaceuticals is in the 51-100 employee band.

How does Sprout Pharmaceuticals' funding compare to other Biotechnology startups?

Sprout Pharmaceuticals' latest round of $25.1M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Sprout Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sprout Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.